A detailed history of First Pacific Financial transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First Pacific Financial holds 978 shares of VRTX stock, worth $441,048. This represents 0.14% of its overall portfolio holdings.

Number of Shares
978
Previous 924 5.84%
Holding current value
$441,048
Previous $433,000 4.85%
% of portfolio
0.14%
Previous 0.14%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$460.0 - $505.78 $24,840 - $27,312
54 Added 5.84%
978 $454,000
Q2 2024

Jul 19, 2024

BUY
$392.81 - $485.53 $10,213 - $12,623
26 Added 2.9%
924 $433,000
Q1 2024

Apr 24, 2024

BUY
$407.69 - $446.08 $25,276 - $27,656
62 Added 7.42%
898 $375,000
Q4 2023

Jan 17, 2024

BUY
$343.0 - $410.68 $18,179 - $21,766
53 Added 6.77%
836 $340,000
Q3 2023

Oct 23, 2023

BUY
$338.18 - $362.46 $54,785 - $58,718
162 Added 26.09%
783 $272,000
Q2 2023

Aug 08, 2023

BUY
$314.42 - $351.91 $195,254 - $218,536
621 New
621 $218,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track First Pacific Financial Portfolio

Follow First Pacific Financial and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Pacific Financial, based on Form 13F filings with the SEC.

News

Stay updated on First Pacific Financial with notifications on news.